Cargando…

Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin

Detalles Bibliográficos
Autores principales: DuPont, Herbert L., Wolf, Ray A., Israel, Robert J., Pimentel, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192100/
https://www.ncbi.nlm.nih.gov/pubmed/27795384
http://dx.doi.org/10.1128/AAC.02165-16
_version_ 1782487726039236608
author DuPont, Herbert L.
Wolf, Ray A.
Israel, Robert J.
Pimentel, Mark
author_facet DuPont, Herbert L.
Wolf, Ray A.
Israel, Robert J.
Pimentel, Mark
author_sort DuPont, Herbert L.
collection PubMed
description
format Online
Article
Text
id pubmed-5192100
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-51921002017-01-09 Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin DuPont, Herbert L. Wolf, Ray A. Israel, Robert J. Pimentel, Mark Antimicrob Agents Chemother Letter to the Editor American Society for Microbiology 2016-12-27 /pmc/articles/PMC5192100/ /pubmed/27795384 http://dx.doi.org/10.1128/AAC.02165-16 Text en Copyright © 2016 DuPont et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
DuPont, Herbert L.
Wolf, Ray A.
Israel, Robert J.
Pimentel, Mark
Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin
title Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin
title_full Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin
title_fullStr Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin
title_full_unstemmed Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin
title_short Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin
title_sort antimicrobial susceptibility of staphylococcus isolates from the skin of patients with diarrhea-predominant irritable bowel syndrome treated with repeat courses of rifaximin
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192100/
https://www.ncbi.nlm.nih.gov/pubmed/27795384
http://dx.doi.org/10.1128/AAC.02165-16
work_keys_str_mv AT dupontherbertl antimicrobialsusceptibilityofstaphylococcusisolatesfromtheskinofpatientswithdiarrheapredominantirritablebowelsyndrometreatedwithrepeatcoursesofrifaximin
AT wolfraya antimicrobialsusceptibilityofstaphylococcusisolatesfromtheskinofpatientswithdiarrheapredominantirritablebowelsyndrometreatedwithrepeatcoursesofrifaximin
AT israelrobertj antimicrobialsusceptibilityofstaphylococcusisolatesfromtheskinofpatientswithdiarrheapredominantirritablebowelsyndrometreatedwithrepeatcoursesofrifaximin
AT pimentelmark antimicrobialsusceptibilityofstaphylococcusisolatesfromtheskinofpatientswithdiarrheapredominantirritablebowelsyndrometreatedwithrepeatcoursesofrifaximin